OTCMKTS:SMMNY

Siemens Healthineers Competitors

$27.97
-0.16 (-0.57 %)
(As of 04/14/2021 03:59 PM ET)
Add
Compare
Today's Range
$27.85
Now: $27.97
$28.20
50-Day Range
$26.29
MA: $27.63
$28.51
52-Week Range
$20.02
Now: $27.97
$30.90
Volume49,091 shs
Average Volume45,496 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Siemens Healthineers (OTCMKTS:SMMNY) Vs. OLK, OCDX, BDSX, LHDX, NOTV, and AKU

Should you be buying SMMNY stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Siemens Healthineers, including Olink Holding AB (publ) (OLK), Ortho Clinical Diagnostics (OCDX), Biodesix (BDSX), Lucira Health (LHDX), Inotiv (NOTV), and Akumin (AKU).

Olink Holding AB (publ) (NASDAQ:OLK) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Valuation and Earnings

This table compares Olink Holding AB (publ) and Siemens Healthineers' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Olink Holding AB (publ)N/AN/AN/AN/AN/A
Siemens HealthineersN/AN/AN/AN/AN/A

Profitability

This table compares Olink Holding AB (publ) and Siemens Healthineers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Olink Holding AB (publ)N/AN/AN/A
Siemens HealthineersN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Olink Holding AB (publ) and Siemens Healthineers, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Olink Holding AB (publ)0000N/A
Siemens Healthineers24802.43

Summary

Siemens Healthineers beats Olink Holding AB (publ) on 1 of the 1 factors compared between the two stocks.

Ortho Clinical Diagnostics (NASDAQ:OCDX) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Earnings & Valuation

This table compares Ortho Clinical Diagnostics and Siemens Healthineers' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ortho Clinical DiagnosticsN/AN/AN/AN/AN/A
Siemens HealthineersN/AN/AN/AN/AN/A

Profitability

This table compares Ortho Clinical Diagnostics and Siemens Healthineers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ortho Clinical DiagnosticsN/AN/AN/A
Siemens HealthineersN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Ortho Clinical Diagnostics and Siemens Healthineers, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ortho Clinical Diagnostics011102.92
Siemens Healthineers24802.43

Ortho Clinical Diagnostics presently has a consensus price target of $24.2727, indicating a potential upside of 30.22%. Given Ortho Clinical Diagnostics' stronger consensus rating and higher probable upside, research analysts plainly believe Ortho Clinical Diagnostics is more favorable than Siemens Healthineers.

Summary

Ortho Clinical Diagnostics beats Siemens Healthineers on 3 of the 3 factors compared between the two stocks.

Siemens Healthineers (OTCMKTS:SMMNY) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Siemens Healthineers and Biodesix, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Siemens Healthineers24802.43
Biodesix00403.00

Biodesix has a consensus target price of $26.00, indicating a potential upside of 37.13%. Given Biodesix's stronger consensus rating and higher possible upside, analysts plainly believe Biodesix is more favorable than Siemens Healthineers.

Profitability

This table compares Siemens Healthineers and Biodesix's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Siemens HealthineersN/AN/AN/A
BiodesixN/AN/AN/A

Valuation & Earnings

This table compares Siemens Healthineers and Biodesix's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siemens HealthineersN/AN/AN/AN/AN/A
BiodesixN/AN/AN/AN/AN/A

Summary

Biodesix beats Siemens Healthineers on 2 of the 3 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Lucira Health and Siemens Healthineers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lucira HealthN/AN/AN/A
Siemens HealthineersN/AN/AN/A

Valuation & Earnings

This table compares Lucira Health and Siemens Healthineers' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucira HealthN/AN/AN/AN/AN/A
Siemens HealthineersN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Lucira Health and Siemens Healthineers, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lucira Health10202.33
Siemens Healthineers24802.43

Lucira Health currently has a consensus target price of $9.00, suggesting a potential downside of 1.10%. Given Lucira Health's higher possible upside, equities research analysts plainly believe Lucira Health is more favorable than Siemens Healthineers.

Summary

Siemens Healthineers beats Lucira Health on 2 of the 3 factors compared between the two stocks.

Inotiv (NASDAQ:NOTV) and Siemens Healthineers (OTCMKTS:SMMNY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Valuation & Earnings

This table compares Inotiv and Siemens Healthineers' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InotivN/AN/AN/AN/AN/A
Siemens HealthineersN/AN/AN/AN/AN/A

Profitability

This table compares Inotiv and Siemens Healthineers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
InotivN/AN/AN/A
Siemens HealthineersN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for Inotiv and Siemens Healthineers, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Inotiv0000N/A
Siemens Healthineers24802.43

Summary

Siemens Healthineers beats Inotiv on 1 of the 1 factors compared between the two stocks.

Siemens Healthineers (OTCMKTS:SMMNY) and Akumin (NASDAQ:AKU) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Siemens Healthineers and Akumin, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Siemens Healthineers24802.43
Akumin00103.00

Profitability

This table compares Siemens Healthineers and Akumin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Siemens HealthineersN/AN/AN/A
AkuminN/AN/AN/A

Valuation and Earnings

This table compares Siemens Healthineers and Akumin's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siemens HealthineersN/AN/AN/AN/AN/A
AkuminN/AN/AN/AN/AN/A

Insider & Institutional Ownership

30.4% of Akumin shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Akumin beats Siemens Healthineers on 2 of the 3 factors compared between the two stocks.

Ad Mining News Daily
Under-the-Radar Gold stock
Could this rare gold-stock alert be the next golden stock pick?

Siemens Healthineers Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
OLK
Olink Holding AB (publ)
0.0$38.53-0.1%$4.58 billionN/A0.00News Coverage
Ortho Clinical Diagnostics logo
OCDX
Ortho Clinical Diagnostics
1.8$18.77-1.3%$4.12 billionN/A0.00
Biodesix logo
BDSX
Biodesix
1.6$18.96-0.4%$503.92 millionN/A0.00
Lucira Health logo
LHDX
Lucira Health
1.1$9.10-2.3%$350.67 millionN/A0.00Analyst Downgrade
Analyst Revision
NOTV
Inotiv
0.0$22.05-0.2%$244.88 millionN/A0.00Analyst Downgrade
Akumin logo
AKU
Akumin
0.6$3.08-0.6%$216.15 millionN/A0.00Analyst Upgrade
Decrease in Short Interest
Relay Medical logo
RYMDF
Relay Medical
0.0$0.47-4.2%$68.93 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
Global WholeHealth Partners logo
GWHP
Global WholeHealth Partners
0.0$0.72-4.2%$48.95 millionN/A0.00Gap Down
Epigenomics logo
EPGNY
Epigenomics
0.6$13.77-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
ETAH
Eternity Healthcare
0.6$0.00-0.0%$0.00N/A0.00
MEDD
Medical Imaging
0.4$0.01-0.0%$0.00N/A0.00Gap Down
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.02-0.0%$0.00N/A0.00
WUXIF
WuXi AppTec
1.0$19.88-0.0%$0.00N/A0.00Decrease in Short Interest
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.